NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Phenex Pharmaceuticals AG

Phenex Pharmaceuticals AG

Private
HeidelbergHealthcare & Life Scienceshttp://phenex-pharma.com/

Last Round

M&A

Jan 6, 2015

Total Funding Raised

$19.6M

Company Overview

Phenex Pharmaceuticals AG is a biotechnology company that specializes in the discovery and development of small-molecule drugs for liver, gastrointestinal, and cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

small-molecule drug discoverybiotechnologynuclear receptorsdrug discovery servicesmedicinal chemistrybiotech R&Ddrug licensingmetabolic disease researchoncology researchpreclinical developmenttherapeutic targetspharma partneringdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phenex Pharmaceuticals AG Comparables

Compare Phenex Pharmaceuticals AG with similar companies based on industry and business-model similarity.

Phenex Pharmaceuticals AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lead Pharma
84%
Orphagen Pharmaceuticals
83%
WMT AG
78%

Phenex Pharmaceuticals AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AJan 6, 2015
Series CSep 21, 2010
Series BOct 2, 2008

Phenex Pharmaceuticals AG Investors

Notable investors and investment history

Phenex Pharmaceuticals AG investors
InvestorRounds
CD-VentureSeries C
Creathor VentureSeries B
KfW Development BankSeries B, Series C
LBBW Venture CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 21, 2010

    Raised $8M from LBBW Venture Capital, Swiss Life, and others.

  • Oct 2, 2008

    $12M round led by Creathor Venture.

Phenex Pharmaceuticals AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phenex Pharmaceuticals AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phenex Pharmaceuticals AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersHeidelberg
Employee Range5
Year Founded2002
Last FundingJan 6, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.